# Leadership, Planning and Evaluation

> **NIH NIH P30** · GEORGETOWN UNIVERSITY · 2022 · $180,941

## Abstract

ABSTRACT
Leadership, Planning and Evaluation is carried out through LCCC's leadership, internal and
external advisory groups. The LCCC Executive Committee (EC) includes Louis M. Weiner
(Director), Michael B. Atkins (Deputy Director), Giuseppe Giaccone (AD, Clinical Research),
Marc Schwartz (AD, Population Research), Anton Wellstein (AD, Basic/Translational
Research), Michael Vander Hoek (AD, Administration), Lucile Adams-Campbell (AD,
Minority Health/Health Disparities), Steven Byers (AD, Shared Resources), Michael Johnson
(AD, Education). Christopher Gallagher, Andre Goy, Andrew Pecora and Sandra Swain
represent the MedStar Georgetown Cancer Institute, the John Theurer Cancer Center,
Hackensack Meridian Health and Georgetown University Medical Center, respectively.
Stanton L. Gerson (Case Comprehensive Cancer Center) chairs LCCC's External Advisory
Committee. Sandra Swain chairs LCCC's Internal Advisory Committee. The EC oversees the
Program Leaders, Shared Resources, Clinical Research Oversight and Education and
Mentoring committees. Robust strategic planning supported the LCCC Consortium with
JTCC, reaffirmed the current LCCC program structure, prioritized five crosscutting initiatives
and guided LCCC's commitment to its catchment areas by expanding clinical services and
catchment-area focused research. Guided by the LCCC Strategic Plan, these actions have
included the addition of 59 new LCCC members. Future plans include recruiting a senior
scientist charged with nurturing collaborative CCSG focused research that fully engages
LCCC investigators in DC and NJ; this will be of particular importance in an expanding effort
in hematologic malignancies and cellular therapy research. Existing strategic planning and
evaluation activities will continue to help LCCC achieve its strategic objectives to 1) advance
transformative cancer research, 2) reduce the impact of cancer and diminish disparities in our
catchment area, 3) lead high-impact clinical research, and 4) ensure long-term growth,
vibrancy and stability of the research enterprise. Specific aims are: 1) Promote the aims of
each LCCC research program according to the LCCC Strategic Plan through recruitment,
investment in shared resources and continued development of LCCC's crosscutting initiatives;
2) Support the continued development of the LCCC Consortium with JTCC; 3) Use the LCCC
EC to promote cohesive, senior leader-led collaborations to foster transdisciplinary, multi-
investigator research; 4) Address the needs of the LCCC catchment areas; and, 5) Expand
the LCCC funding base and interventional clinical trial accruals.

## Key facts

- **NIH application ID:** 10400662
- **Project number:** 5P30CA051008-29
- **Recipient organization:** GEORGETOWN UNIVERSITY
- **Principal Investigator:** Louis M. Weiner
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $180,941
- **Award type:** 5
- **Project period:** 1997-08-15 → 2024-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10400662

## Citation

> US National Institutes of Health, RePORTER application 10400662, Leadership, Planning and Evaluation (5P30CA051008-29). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10400662. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*